Hottest Stories: Rio Tinto plc (NYSE:RIO), Novavax (NASDAQ:NVAX), ZS Pharma (NASDAQ:ZSPH), CSX Corp. (NYSE:CSX), Avon Products (NYSE:AVP)

Posted by on Sep 13, 2015

Rio Tinto plc (NYSE:RIO) shares moved up 2.28% in last trading session and ended the day at $37.21. RIO has a return on assets of 8.60%. Rio Tinto plc (NYSE:RIO) quarterly performance is -13.19%.

Rio Tinto plc (Rio Tinto) is a global mining company. Rio Tinto focuses on finding, mining, and processing the Earth’s mineral resources. The Company operates through five product groups, including aluminum, copper, diamonds and minerals, energy product and iron ore.

Rio Tinto plc (NYSE:RIO) was upgraded by JPMorgan Chase & Co. to a “buy” rating in a report issued on Friday, Analyst Ratings Net reports. The firm presently has a GBX 2,850 ($43.28) price objective on the stock.

Novavax, Inc. (NASDAQ:NVAX) ended the last trading day at $10.00. Company weekly volatility is calculated as 4.95% and price to cash ratio as 8.56. Novavax, Inc. (NASDAQ:NVAX) showed a weekly performance of -3.94%.

Novavax, Inc. (Novavax) is a clinical-stage vaccine company engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company through its recombinant nanoparticle vaccine technology produces vaccine candidates to respond to both known and newly emerging diseases.

Novavax (NASDAQ:NVAX) announced that the full data set from its clinical trial of the RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in women of childbearing age (18-35 years) were published in the Journal of Infectious Disease. The Company previously announced top-line results from the trial.

ZS Pharma, Inc. (NASDAQ:ZSPH) confirmed that it has participated in preliminary discussions with Actelion Ltd. (OTC:ALIOF) regarding a potential strategic transaction. ZS Pharma regularly and routinely explores opportunities with various strategic partners and will continue to do so. These discussions may or may not lead to any transaction. ZS Pharma does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.
ZS Pharma is a publicly-traded (Nasdaq:ZSPH), biopharmaceutical company with offices in Redwood City, California and Coppell, Texas. ZS Pharma’s lead therapeutic candidate, ZS-9 (sodium zirconium cyclosilicate), is an investigational treatment for hyperkalemia that has been submitted to the FDA for potential approval for the treatment of hyperkalemia.
On 11 September, ZS Pharma, Inc. (NASDAQ:ZSPH) shares moved up 3.02% and was closed at $76.99. ZS Pharma, Inc. (NASDAQ:ZSPH) year to date (YTD) performance is 85.21%.

CSX Corp. (NYSE:CSX) shares moved up 1.71% in last trading session and ended the day at $28.50. CSX Gross Margin is 70.40% and its has a return on assets of 6.00%. CSX Corp. (NYSE:CSX) quarterly performance is -17.42%.

CSX Corporation (CSX), together with its subsidiaries, is a transportation company. The Company provides rail-based transportation services, including traditional rail service and the transport of intermodal containers and trailers. The Company has three lines of business: merchandise business, coal business and the intermodal business. The Company’s merchandise business transports aggregates (which include crushed stone, sand and gravel), metal, phosphate, fertilizer, food, consumer (manufactured goods and appliances), agricultural, automotive, paper and chemical products.

Fredrik Eliasson, CSX Corporation (NYSE: CSX) executive vice president and chief sales and marketing officer, will address Morgan Stanley’s 3rd Annual Laguna Conference on Thursday, September 17, 2015, at 11:10 a.m. Eastern Time (8:10 a.m. Pacific Time).

Avon Products, Inc. is a manufacturer and marketer of beauty and related products. The Company’s offers its products under two product categories: Beauty and Fashion & Home. Beauty consists of skincare (which includes personal care), fragrance and color (cosmetics). Fashion & Home consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and nutritional products.
Avon Products Inc. (NYSE:AVP) caters to the Consumer Goods space. It has a net profit margin of -4.40% and weekly performance is -26.11%. On the last day of trading company shares ended up $3.48. Avon Products Inc. (NYSE:AVP) distance from 50-day simple moving average (SMA50) is -36.20%.

A private-equity investment sparked concerns about the Avon Products Inc. (NYSE:AVP)’s financial condition. The Wall Street Journal reported on Thursday that Avon was considering selling a stake to firms such as Cerberus Capital Management and Platinum Equity, using an approach called a private investment in public equity, or PIPE.

Leave a Reply

Your email address will not be published. Required fields are marked *